Studies on psychotropic drugs. XI. Pharmacology of 3-chloro-5- (3- (4-piperidino-4-carbamoyl-piperidino) -propyl) -10,11-dihydro- (5H) -dibenz- (b,f) -azepine dihydrochloride monohydrate
Nakanishi, M.; Tsumagari, T.; Nakanishi, A.
Arzneimittel-Forschung 21(3): 391-395
1971
ISSN/ISBN: 0004-4172 PMID: 5107978 Document Number: 41646
Document emailed within 1 workday
Related Documents
Haaz, M.C.; Riché, C.; Rivory, L.P.; Robert, J. 1998: Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(8): 769-774Rostock, K.J.; Rathgen, K.; Pfeiffer, D.; Rostock, G. 1985: Clinico-electrophysiologic studies on the action of the anti-arrhythmic substance 3-carbethoxyamino-5-dimethylamino-acetyl-10,11-dihydro-5H- dibenz[b,f]azepine hydrochloride (Bonnecor, AWD 19-166, GS 015) Die Pharmazie 40(12): 862-864
Adamus, W.S.; Oldigs-Kerber, J.; Lohmann, H. 1987: Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers Arzneimittel-Forschung 37(5): 569-572
Asami, Y.; Otsuka, M.; Hirohashi, T.; Inaba, S.; Yamamoto, H. 1974: The synthesis and pharmacology of a novel benzodiazepine derivative, 1-methyl-5-(o-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one(ID-540) Arzneimittel-Forschung 24(10): 1563-1568
Carron, C.; Jullien, A.; Bucher, B. 1971: Synthesis and pharmacological properties of a series of 2-piperidino alkanol derivatives Arzneimittel-Forschung 21(12): 1992-1998
Küttel, S.; Rácz, I.; Korbonits, D. 1982: In vitro resorption study of a new anti-arrhythmia compound, N-(3,3-diphenyl-propyl)-N'-(1-phenyl-2-propyl)1,3-propylene diamine dihydrochloride Acta Pharmaceutica Hungarica 52(2): 81-90
Dall'Asta, L.; Cixpelletti, G.M.; Pedrazzoli, A. 1973: Derivatives of tetramethylated cyclic amines. II. 1-Substituted 3-tetramethyl-piperidino- (or pyrrolidino-, pyrrolino-, tetrahydropyridino-)-propan-2-ols Arzneimittel-Forschung 23(2): 278-281
Pesák, M.; Kopecký, F.; Benes, L.; Borovanský, A.; Kopácová, L. 1972: Local anesthetics. XLIV. Relations between physico-chemical parameters and the relative surface local anesthetic activity of piperidino-isopropyl carbanilates Ceskoslovenska Farmacie 21(7): 315-318
Bahna, L.; Podaný, V.; Benesová, M.; Godál, A.; Vachálková, A. 1978: Carcinogenicity and polarographic behavior of dibenz[a,h]anthracene, dibenz[a,h]acridine and dibenz[a,h]phenazine Neoplasma 25(6): 641-645
Kaverina, N.V.; Senova, Z.P.; Lyskovzev, V.V.; Demina, L.M.; Grizenko, A.N.; Skoldinov, A.P.; Femmer, K.; Poppe, H.; Stark, A.; Wunderlich, H. 1985: Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines Die Pharmazie 40(12): 830-832
Mayr, C.A.; Sami, S.M.; Remers, W.A.; Dorr, R.T. 1998: Identification and characterization of in vitro metabolites of 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-dione (Azonafide) Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(2): 105-109
Guo, H.Y.; Sun, L.Y.; Tang, Y.; Yan, G.H.; Zhang, Z.P. 1988: Studies on pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and antibacterial activity of 7-chloro-6-fluoro-1-ethyt-1, 4-dihydro-4-oxopyrido(2,3-c)pyridazine-3-carboxylic acid and derivatives Yao Xue Xue Bao 23(8): 566-573
Wieczorek, J.; Mordarski, M.; Rykowski, A.; Nantka-Namirski, P. 1985: Antifungal properties of 1,2-dihydro-3-methylpyrido-(3,2-e)-as-triazine dihydrochloride (I-476) Archivum Immunologiae et Therapiae Experimentalis 33(2): 339-344
Hensel, I.; Bretschneider, H.J.; Kettler, D.; Knoll, D.; Kochsiek, K.; Reploh, H.D.; Spieckermann, P.G.; Tauchert, M. 1972: Effect of 1,4-bis(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine dihydrochloride on cardiac metabolism, hemodynamics and coronary and renal blood flow Arzneimittel-Forschung 22(4): 652-663
Castles, T.R.; Loth, E.; Crawford, C.R.; Lee, C.C. 1970: The neuromuscular blocking properties of the antimalarial agent, bis((chloro-7"-quinolyl-4")amino-2'-propyl)-1,4-piperazine Journal of Pharmacology and Experimental Therapeutics 172(1): 44-51
Gilbert, R.M.; Knight, M. 1977: Patient-drug monitoring. Laboratory studies for psychotropic drugs Journal of the Kansas Medical Society 78(1): 20-22
Fukuda, T.; Itoh, K.; Nose, T. 1981: Antiulcerogenic action of 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one (KB-509), a new benzodiazepine derivative Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 77(3): 273-280
Lan, S.J.; Chando, T.J.; Cohen, A.I.; Weliky, I.; Schreiber, E.C. 1973: Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(4): 619-627
Zieliński, H. 1973: Cleavage of the quinuclidine ring system based on the example of chloro-9-deoxy-dihydro quinine alkaloids. Ii Acta Poloniae Pharmaceutica 30(2): 155-159
Oelschläger, H.; Sengün, F.I. 1974: Polarographic determination of lorazepam (7-chloro-1,3-dihydro-3-hydroxy-5-o-chlorophenyl-2H-1,4-benzodiazepin-2-one). 16. Drug analyses using polarography or oscillopolarography Die Pharmazie 29(12): 770-773